Brief: Targovax Granted European Patent For Oncos-102
Oct 12 (Reuters) - Targovax ASA TRVX.OL :
* TARGOVAX GRANTED EUROPEAN PATENT FOR ONCOS-102 IN COMBINATION WITH CHECKPOINT INHIBITORS
* PATENT COVERS USE OF ONCOS-102 IN COMBINATION WITH CHECKPOINT INHIBITORS
* EUROPEAN PATENT OFFICE HAS GRANTED EUROPEAN PATENT NO 3293201
Source text for Eikon: ID:nWkr2Npn1y
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration